1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Immunoglobulin A Nephropathy: new trials by email Literature Review of Immunoglobulin A Nephropathy trials Research Report on Immunoglobulin A Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy. Corticosteroid, Renin-angiotensin sytem blockers, Sodium-glucose cotransporter 2 inhibitor - Glomerulonephritis, Immunoglobulin A Nephropathy | Phase 4 | Recruiting | Fondazione Schena | 878 | 2023-05-01 | 2025-04-02 |
Glomerulonephritis (1) · Glomerulonephritis, IGA (1)
Autoimmune Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Adrenal Cortex Hormones (1) · Canagliflozin (1) · Lisinopril (1) · Losartan (1) · Methylprednisolone Hemisuccinate (1) · Prednisolone (1) · Ramipril (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · dapagliflozin (1) · empagliflozin (1)
Italy (1)
PMID 15851648, PMID 17533019, PMID 17978307, PMID 19571790, PMID 19571791, PMID 21606384, PMID 21852672, PMID 24029421, PMID 25018935, PMID 25585823, PMID 26630142, PMID 28341274, PMID 28763548, PMID 30177015, PMID 32409237, PMID 32889014, PMID 32970396, PMID 32998816, PMID 33023926, PMID 37772889, PMID 38299639, PMID 38770818, PMID 9100040